India's Strategic Investment in BioPharma SHAKTI and Chemical Parks
India is investing ₹13,000 crore in BioPharma SHAKTI and three dedicated chemical parks, marking a significant step towards enhancing its global chemical sector presence, aiming for a market share increase to 5-6% by 2030.
Source: Original Link